|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 9/127 | |
| A61K 31/704 | |||
| A61K 31/137 | |||
| A61K 47/48 | |||
| A61P 35/00 |
| (11) | Patento numeris | 1140022 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 99963103.9 |
| Europos patento paraiškos padavimo data | 1999-12-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2001-10-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2008-02-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US1999/030230 |
| Data | 1999-12-17 |
| (87) | Numeris | WO 2000/035422 |
| Data | 2000-06-22 |
| (30) | Numeris | Data | Šalis |
| 113004 P | 1998-12-18 | US |
| (72) |
GABIZON, Alberto, A., IL
ZALIPSKY, Samuel, US
GOREN-RUBEL, Dorit, IL
HOROWITZ, Aviva, T., IL
|
| (73) |
ALZA CORPORATION,
1900 Charleston Road, P.O. Box 7210, Building M10-3, Mountain View, CA 94039-7210,
US
HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT COMPANY, LTD., Kiryat Hadassah, P.O. Box 12000, 91120 Jerusalem, IL |
| (54) | METHOD OF ADMINISTERING A COMPOUND TO MULTI-DRUG RESISTANT CELLS |
| METHOD OF ADMINISTERING A COMPOUND TO MULTI-DRUG RESISTANT CELLS |